Ally Financial’s Zimmer Biomet ZBH Stock Holding History

Ally Financial’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72M	Hold	20,000	–	–	0.22%	97
2026 Q1	$1.81M	Hold	20,000	–	–	0.23%	84
2025 Q4	$1.8M	Hold	20,000	–	–	0.22%	83
2025 Q3	$1.97M	Hold	20,000	–	–	0.24%	81
2025 Q2	$1.82M	Buy	20,000 +6,000	+43%	+$580K	0.21%	75
2025 Q1	$1.58M	Hold	14,000	–	–	0.18%	84
2024 Q4	$1.48M	Hold	14,000	–	–	0.18%	81
2024 Q3	$1.51M	Hold	14,000	–	–	0.18%	81
2024 Q2	$1.52M	Buy	+14,000	New	+$1.65M	0.19%	85
2016 Q2	–	Sell	-25,750	Closed	-$2.67M	–	130
2016 Q1	$2.67M	Hold	25,750	–	–	0.37%	83
2015 Q4	$2.56M	Hold	25,750	–	–	0.36%	72
2015 Q3	$2.35M	Hold	25,750	–	–	0.24%	96
2015 Q2	$2.73M	Hold	25,750	–	–	0.28%	79
2015 Q1	$2.94M	Hold	25,750	–	–	0.3%	90
2014 Q4	$2.83M	Buy	25,750 +10,300	+67%	+$1.09M	0.31%	101
2014 Q3	$1.51M	Buy	+15,450	New	+$1.52M	0.21%	126

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ally Financial's ZBH Position: Q2 2026 in Review

Ally Financial held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 20,000 shares worth $1.72M. The position accounts for 0.22% of the portfolio, ranked #97.

Ally Financial first reported a position in ZBH in Q3 2014 and has held it in 16 quarters since. The position peaked at $2.94M in Q1 2015. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Ally Financial held 20,000 shares of Zimmer Biomet worth $1.72M as of Q2 2026.
Ally Financial left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up 0.22% of Ally Financial's portfolio in Q2 2026, its #97 holding.
Ally Financial first reported a position in Zimmer Biomet in Q3 2014 and has held it in 16 quarters since.
Ally Financial's Zimmer Biomet position peaked at $2.94M in Q1 2015.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ally Financial's 13F filing for Q2 2026, filed 13 Aug 2026.